Year archive

CLARITY PHARMACEUTICALS LTD — 2025 filings

All 114 regulatory filings released by CLARITY PHARMACEUTICALS LTD (CU6) in 2025, sourced directly from the official regulator.

114 Filings

2025 Period

2025 filings (114)

Filing	Released	Lang
Co-PSMA abstract accepted for oral presentation at EAU 4 pages 361.0KB Regulatory Filings	2025-12-23	English
Positive guidance from the US FDA on Cu-64 SARTATE Phase III 3 pages 219.6KB Regulatory Filings	2025-12-21	English
Clarity to present DISCO trial data at ASCO-GI 2026 4 pages 242.5KB Regulatory Filings	2025-12-08	English
Notification regarding unquoted securities - CU6 6 pages 18.5KB Share Issue/Capital Change	2025-12-07	English
Notification regarding unquoted securities - CU6 8 pages 27.1KB Share Issue/Capital Change	2025-12-01	English
Ceasing to be a substantial holder 20 pages 1.3MB Major Shareholding Notification	2025-11-30	English
Change of Director's Interest Notice - A Taylor 4 pages 272.8KB Director's Dealing	2025-11-27	English
Change of Director's Interest Notice - C Biggin 3 pages 261.9KB Director's Dealing	2025-11-27	English
Change of Director's Interest Notice - M Parker 3 pages 262.2KB Director's Dealing	2025-11-27	English
Becoming a substantial holder 29 pages 2.4MB Major Shareholding Notification	2025-11-26	English
AGM MD Presentation 24 pages 3.7MB AGM Information	2025-11-24	English
Chairperson Address AGM 4 pages 211.9KB AGM Information	2025-11-24	English
Results of Meeting 1 page 11.8KB Declaration of Voting Results & Voting Rights Announcements	2025-11-24	English
Ceasing to be a substantial holder 18 pages 1.5MB Major Shareholding Notification	2025-11-23	English
Becoming a substantial holder 28 pages 2.4MB Major Shareholding Notification	2025-11-13	English
Application for quotation of securities - CU6 6 pages 18.9KB Share Issue/Capital Change	2025-11-10	English
Cleansing Notice 1 page 179.2KB Capital/Financing Update	2025-11-10	English
Ceasing to be a substantial holder 18 pages 1.3MB Major Shareholding Notification	2025-11-06	English
Change in substantial holding 18 pages 969.3KB Major Shareholding Notification	2025-11-04	English
Change in substantial holding 5 pages 290.0KB Major Shareholding Notification	2025-11-03	English
Quarterly Activities/Appendix 4C Cash Flow Report 27 pages 4.7MB Interim / Quarterly Report	2025-10-30	English
Response to ASX Aware Letter 8 pages 1.2MB Regulatory Filings	2025-10-26	English
Ceasing to be a substantial holder 4 pages 499.0KB Major Shareholding Notification	2025-10-23	English
Becoming a substantial holder 21 pages 2.3MB Major Shareholding Notification	2025-10-22	English
Notice of Annual General Meeting/Proxy Form 27 pages 1.4MB AGM Information	2025-10-20	English
Canaccord Drug and Device Conference presentation 12 pages 2.3MB Investor Presentation	2025-10-20	English
Clarity signs copper-67 Supply Agreement with Nusano 2 pages 182.6KB Capital/Financing Update	2025-10-15	English
Co-PSMA trial achieves primary endpoint 4 pages 329.0KB Regulatory Filings	2025-10-13	English
Becoming a substantial holder 6 pages 306.4KB Major Shareholding Notification	2025-10-08	English
Change in substantial holding 23 pages 1.3MB Major Shareholding Notification	2025-10-07	English
Data on SAR-bisFAP to be presented at WMIC 2025 2 pages 230.0KB Regulatory Filings	2025-10-01	English
Clarity response to US tariff announcement 1 page 1 Regulatory Filings	2025-09-25	English
Ceasing to be a substantial holder 6 pages 225.3KB Major Shareholding Notification	2025-09-22	English
Date of AGM 1 page 196.4KB AGM Information	2025-09-22	English
Ceasing to be a substantial holder 5 pages 318.5KB Major Shareholding Notification	2025-09-22	English
Becoming a substantial holder 20 pages 473.1KB Major Shareholding Notification	2025-09-17	English
Becoming a substantial holder 8 pages 277.1KB Major Shareholding Notification	2025-09-11	English
Ceasing to be a substantial holder 6 pages 222.3KB Major Shareholding Notification	2025-09-08	English
Annual Report to shareholders 119 pages 8.4MB Annual Report	2025-09-04	English
Appendix 4G 14 pages 951.6KB Regulatory Filings	2025-09-04	English
Corporate Governance Statement 21 pages 806.7KB Governance Information	2025-09-04	English
Becoming a substantial holder 8 pages 276.1KB Major Shareholding Notification	2025-09-02	English
Change in substantial holding 32 pages 2.3MB Major Shareholding Notification	2025-09-01	English
Preliminary Final Report 78 pages 10.1MB Annual Report	2025-08-27	English
Application for quotation of securities - CU6 6 pages 18.3KB Share Issue/Capital Change	2025-08-10	English
Cleansing Notice 1 page 178.5KB Regulatory Filings	2025-08-10	English
Change in substantial holding 30 pages 2.0MB Major Shareholding Notification	2025-08-07	English
Notification regarding unquoted securities - CU6 6 pages 19.3KB Share Issue/Capital Change	2025-08-03	English
Application for quotation of securities - CU6 7 pages 21.3KB Share Issue/Capital Change	2025-08-03	English
Cleansing Notice 1 page 263.0KB Capital/Financing Update	2025-08-03	English
Cleansing Notice 2 pages 453.5KB Capital/Financing Update	2025-07-31	English
Ceasing to be a substantial holder 2 pages 386.3KB Major Shareholding Notification	2025-07-31	English
Ceasing to be a substantial holder 2 pages 391.0KB Major Shareholding Notification	2025-07-31	English
Ceasing to be a substantial holder 2 pages 144.7KB Major Shareholding Notification	2025-07-31	English
Application for quotation of securities - CU6 5 pages 16.4KB Share Issue/Capital Change	2025-07-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 33 pages 10.0MB Interim / Quarterly Report	2025-07-30	English
Ceasing to be a substantial holder 4 pages 494.2KB Major Shareholding Notification	2025-07-30	English
Becoming a substantial holder 22 pages 2.2MB Major Shareholding Notification	2025-07-28	English
Clarity successfully completes $203 million institutional pl 4 pages 311.8KB Capital/Financing Update	2025-07-27	English
Proposed issue of securities - CU6 5 pages 17.6KB Capital/Financing Update	2025-07-27	English
Change in substantial holding 27 pages 1.8MB Major Shareholding Notification	2025-07-23	English
Co-PSMA trial recruitment successfully completed 4 pages 317.2KB Regulatory Filings	2025-07-16	English
Notification of cessation of securities - CU6 4 pages 14.8KB Regulatory Filings	2025-07-13	English
Change of Director's Interest Notice - A Taylor 3 pages 271.6KB Director's Dealing	2025-07-03	English
Change of Director's Interest Notice - C Biggin 3 pages 271.7KB Director's Dealing	2025-07-03	English
Change of Director's Interest Notice - M Parker 3 pages 271.6KB Director's Dealing	2025-07-03	English
Notice of initial substantial holder 2 pages 200.2KB Major Shareholding Notification	2025-07-03	English
Application for quotation of securities - CU6 6 pages 18.3KB Share Issue/Capital Change	2025-07-03	English
Cleansing Notice 1 page 262.5KB Capital/Financing Update	2025-07-03	English
Application for quotation of securities - CU6 7 pages 21.9KB Share Issue/Capital Change	2025-07-01	English
Cleansing Notice 1 page 609.4KB Capital/Financing Update	2025-07-01	English
Change in substantial holding 31 pages 1.5MB Major Shareholding Notification	2025-06-30	English
Application for quotation of securities - CU6 7 pages 21.2KB Share Issue/Capital Change	2025-06-23	English
Cleansing Notice 1 page 262.6KB Regulatory Filings	2025-06-23	English
Clarity enters a Commercial Manufacturing Agreement 4 pages 340.7KB Capital/Financing Update	2025-06-16	English
SABRE topline results 6 pages 420.5KB Capital/Financing Update	2025-06-12	English
Ceasing to be a substantial holder 3 pages 299.6KB Major Shareholding Notification	2025-06-04	English
DISCO topline results 6 pages 400.7KB Capital/Financing Update	2025-06-04	English
Notification regarding unquoted securities - CU6 6 pages 18.6KB Share Issue/Capital Change	2025-05-29	English
First patient imaged in Phase III AMPLIFY trial 4 pages 347.9KB Regulatory Filings	2025-05-28	English
AMPLIFY trial commences 4 pages 356.2KB Regulatory Filings	2025-05-19	English
Ceasing to be a substantial holder 5 pages 547.2KB Major Shareholding Notification	2025-05-14	English
Becoming a substantial holder 27 pages 363.8KB Major Shareholding Notification	2025-05-12	English
Change in substantial holding 26 pages 1.7MB Major Shareholding Notification	2025-05-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 33 pages 8.8MB Interim / Quarterly Report	2025-04-29	English
Change in substantial holding 27 pages 1.6MB Major Shareholding Notification	2025-04-21	English
$11.1 million RDTI and refocus on high-priority programs 5 pages 268.5KB Capital/Financing Update	2025-04-16	English
Clarity signs commercial-scale copper-64 Supply Agreement 3 pages 260.8KB Capital/Financing Update	2025-04-16	English
Ceasing to be a substantial holder 4 pages 477.3KB Major Shareholding Notification	2025-04-16	English
Becoming a substantial holder 25 pages 2.4MB Major Shareholding Notification	2025-04-15	English
First patient treated in the Phase II of the SECuRE trial 4 pages 353.9KB Regulatory Filings	2025-04-14	English
Change of Registered Office and Registry Address 1 Regulatory Filings	2025-04-13	English
Becoming a substantial holder 5 pages 469.4KB Major Shareholding Notification	2025-04-10	English
Notification of cessation of securities - CU6 4 pages 14.8KB Share Issue/Capital Change	2025-04-09	English
Becoming a substantial holder 35 pages 2.5MB Major Shareholding Notification	2025-04-08	English
SECuRE trial update 6 pages 453.5KB Regulatory Filings	2025-03-04	English
Clarity signs Cu-64 Supply Agreement with UQ 4 pages 325.8KB Capital/Financing Update	2025-03-04	English
Application for quotation of securities - CU6 8 pages 21.0KB Share Issue/Capital Change	2025-03-04	English
Cleansing Notice 1 page 262.4KB Capital/Financing Update	2025-03-04	English
Appendix 4D 2 pages 853.1KB Interim / Quarterly Report	2025-02-27	English
Half Yearly Report and Accounts 71 pages 15.3MB Interim / Quarterly Report	2025-02-27	English
Clarity receives US FDA FTD for the treatment of mCRPC 7 pages 614.3KB Regulatory Filings	2025-02-18	English
Response to ASX Cleansing Notice Timing Letter 7 pages 1.2MB Regulatory Filings	2025-02-17	English
Clarity expands pipeline with Cu-64/67 SAR-trastuzumab 4 pages 349.2KB Capital/Financing Update	2025-02-10	English
Application for quotation of securities - CU6 10 pages 27.0KB Share Issue/Capital Change	2025-02-10	English
Cleansing Notice 1 page 262.1KB Regulatory Filings	2025-02-10	English
Quarterly Activities/Appendix 4C Cash Flow Report 34 pages 10.3MB Interim / Quarterly Report	2025-01-30	English
Application for quotation of securities - CU6 11 pages 30.2KB Share Issue/Capital Change	2025-01-28	English
Cleansing Notice 1 page 178.7KB Regulatory Filings	2025-01-28	English
Clarity to present COBRA and CLARIFY abstracts 5 pages 361.2KB Investor Presentation	2025-01-27	English
Clarity receives U.S. FDA Fast Track Designation 4 pages 690.6KB Regulatory Filings	2025-01-23	English
Application for quotation of securities - CU6 8 pages 21.1KB Share Issue/Capital Change	2025-01-21	English
Cleansing Notice 1 page 178.2KB Regulatory Filings	2025-01-21	English
Notification of cessation of securities - CU6 5 pages 16.5KB Regulatory Filings	2025-01-07	English